phosphorus has been researched along with 1-methyl-4-phenylpyridinium in 1 studies
| Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (1-methyl-4-phenylpyridinium) | Trials (1-methyl-4-phenylpyridinium) | Recent Studies (post-2010) (1-methyl-4-phenylpyridinium) |
|---|---|---|---|---|---|
| 48,074 | 1,126 | 17,139 | 1,854 | 1 | 593 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, JP; Cassarino, DS; Fall, CP; Smith, TS | 1 |
1 other study(ies) available for phosphorus and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Benzothiazoles; Biological Transport; Calcium; Corpus Striatum; Dopamine Agents; Humans; Ion Channel Gating; Liver; Male; Microdialysis; Mitochondria; Neuroblastoma; Neuroprotective Agents; Neurotoxins; Parkinson Disease, Secondary; Phosphorus; Porins; Pramipexole; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Thiazoles; Tumor Cells, Cultured | 1998 |